Figures
Philadelphia Life Sciences Figures Report Q4 2024
Increased vacancies loom, yet investment signals market resilience
January 14, 2025 3 Minute Read
Looking for a PDF of this content?
- New lab and R&D projects that are not fully pre-leased are set to add vacancy to the market when they deliver in 2025
- While demand stalled in 2023, activity grew by more than 47% in 2024, pointing toward a recovery.
- Significant VC investment steadily flowed into the life sciences sector, supporting leasing activity and growth initiatives.